Internal Medicine Alert (Vol. 39, No. 1) - January 15, 2017

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: January 2017

Valid through: January 2020

Target Audience

This CME activity is intended for the internist/family physician.


  • Common Triggers of Acute Myocardial Infarction
  • White-coat Hypertension: Does It Predict Cardiovascular Disease?
  • Migraine and Stroke: Data Are Accumulating
  • Pharmacology Update: Insulin Glargine and Lixisenatide Injection (Soliqua)
  • Clinical Briefs: Topical Agent for Premature Ejaculation; Are We Using Novel Oral Anticoagulants Wisely?; Lung Cancer Screening at a VA Medical Center
  • ECG Review: Which Artery is the Culprit?


  • Describe new findings in differential diagnosis and treatment of various diseases;
  • Describe the advantages, disadvantages, and controversies surrounding the latest advances in the diagnosis and treatment of disease;
  • Identify cost-effective treatment regimens;
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available


  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credits
  • 2.0 ABIM MOC Credits


This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation


AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

Internal Medicine Alert has been reviewed and is acceptable for up to 1.0 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins Jan. 1, 2017. Term of approval is for one year from this date with the option of yearly renewal.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty Listing


Stephen A. Brunton, MD

Adjunct Professor of Pharmacy Practice

College of Pharmacy

Roseman University of Health Sciences

Salt Lake City 


James Chan, PharmD, PhD

Pharmacy Quality and Outcomes Manager

Kaiser Permanente

Oakland, CA

Michael H. Crawford, MD

Professor of Medicine, Chief of Clinical Cardiology
University of California, San Francisco


William T. Elliott, MD, FACP

Chair, Formulary Committee

Northern California Kaiser Permanente

Assistant Clinical Professor of Medicine
University of California, San Francisco


Matthew E. Fink, MD

Professor and Chairman
Department of Neurology
Weill Cornell Medical College
New York Presbyterian Hospital


Ken Grauer, MD

Professor Emeritus in Family Medicine

College of Medicine

University of Florida


Harold L. Karpman, MD, FACC, FACP

Clinical Professor of Medicine
David Geffen School of Medicine at UCLA


Louis Kuritzky, MD

Clinical Assistant Professor

University of Florida


Gerald Roberts, MD

Senior Attending Physician
Long Island Jewish Medical Center NS/LIJ Health Care System

New Hyde Park, NY

Financial Disclosure

Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott Diabetes, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Allergan, Janssen, Lilly, Novo Nordisk, and Teva; he serves on the speakers bureau of

AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing Editor Louis Kuritzky, MD, is a retained consultant for and on the speakers bureau of Allergan, Daiichi Sankyo, Lilly, and Lundbeck. Peer Reviewer Gerald Roberts, MD, Executive Editor Leslie Coplin, and Assistant Editor Jonathan Springston report no financial relationships relevant to this field of study.


Drs. Karpman, Crawford, Elliott, and Chan report no financial relationships relevant to this field of study.


Dr. Fink reports he is a retained consultant for Procter & Gamble and Pfizer.


Dr. Grauer is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book.


Copyright 2017, AHC Media. All rights reserved.